The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study.

ABSTRACT:

Background

With efforts underway to develop a universal coronavirus vaccine, otherwise known as a pan-coronavirus vaccine, this is the time to offer potential funders, researchers, and manufacturers guidance on the potential value of such a vaccine and how this value may change with differing vaccine and vaccination characteristics.

Methods

Using a computational model representing the United States (U.S.) population, the spread of SARS-CoV-2 and the various clinical and economic outcomes of COVID-19 such as hospitalisations, deaths, quality-adjusted life years (QALYs) lost, productivity losses, direct medical costs, and total societal costs, we explored the impact of a universal vaccine under different circumstances. We developed and populated this model using data reported

SUBMITTER: Bartsch SM 

PROVIDER: S-EPMC10965405 | biostudies-literature | 2024 Feb

REPOSITORIES: biostudies-literature